PT83939B - Metodo para a producao de factor angiogenico da placenta humana capaz de estimular a sintese de proteases, sintese de dna e migracao de celulas endoteliais capilares - Google Patents
Metodo para a producao de factor angiogenico da placenta humana capaz de estimular a sintese de proteases, sintese de dna e migracao de celulas endoteliais capilaresInfo
- Publication number
- PT83939B PT83939B PT83939A PT8393986A PT83939B PT 83939 B PT83939 B PT 83939B PT 83939 A PT83939 A PT 83939A PT 8393986 A PT8393986 A PT 8393986A PT 83939 B PT83939 B PT 83939B
- Authority
- PT
- Portugal
- Prior art keywords
- angiogenic factor
- synthesis
- stimulate
- proteases
- dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80987385A | 1985-12-17 | 1985-12-17 | |
US88855486A | 1986-07-16 | 1986-07-16 | |
US89582986A | 1986-08-12 | 1986-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT83939A PT83939A (en) | 1987-01-01 |
PT83939B true PT83939B (pt) | 1989-05-31 |
Family
ID=27420052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT83939A PT83939B (pt) | 1985-12-17 | 1986-12-16 | Metodo para a producao de factor angiogenico da placenta humana capaz de estimular a sintese de proteases, sintese de dna e migracao de celulas endoteliais capilares |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0226181B1 (pt) |
JP (1) | JPH10262668A (pt) |
KR (1) | KR960015442B1 (pt) |
AT (1) | ATE107315T1 (pt) |
AU (2) | AU6774887A (pt) |
DE (1) | DE3689921T2 (pt) |
DK (1) | DK424387A (pt) |
ES (1) | ES2056787T3 (pt) |
FI (1) | FI93843C (pt) |
IE (1) | IE863281L (pt) |
IL (1) | IL80944A (pt) |
NO (1) | NO177859C (pt) |
NZ (1) | NZ218631A (pt) |
PT (1) | PT83939B (pt) |
WO (1) | WO1987003885A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852177A (en) * | 1987-02-24 | 1998-12-22 | Takeda Chemical Industries, Ltd. | Basic fibroblast growth factor (bFGF) muteins |
US4900673A (en) * | 1988-03-28 | 1990-02-13 | President And Fellows Of Harvard College | Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
CA2002261A1 (en) * | 1988-11-07 | 1990-05-07 | Andreas Sommer | High molecular weight human angiogenic factors |
HUT67217A (en) * | 1992-02-14 | 1995-03-28 | Kaken Pharma Co Ltd | Remedy for airway diseases |
GB9203533D0 (en) * | 1992-02-19 | 1992-04-08 | Erba Carlo Spa | Use of the conjugate between a fibroblast growth factor and a saporin in treating ocular pathologies |
US6749850B1 (en) * | 1999-08-18 | 2004-06-15 | The General Hospital Corporation | Methods, compositions and kits for promoting recovery from damage to the central nervous system |
AU2003242459B2 (en) | 2002-06-18 | 2007-05-17 | Eisai R&D Management Co., Ltd. | Primary cultured adipocytes for gene therapy |
EP1933852B1 (en) * | 2005-09-27 | 2018-12-19 | TissueTech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
CN111100191A (zh) * | 2018-10-26 | 2020-05-05 | 神威药业集团有限公司 | 源于人胎盘的活性蛋白质或多肽及其用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4209587A (en) * | 1978-12-29 | 1980-06-24 | Monsanto Company | Production of tumor angiogenesis factor by cell culture |
US4225670A (en) * | 1978-12-29 | 1980-09-30 | Monsanto Company | Production of tumor angiogenesis factor by cell culture |
DE3110560A1 (de) * | 1981-03-18 | 1982-10-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben" |
US4529590A (en) * | 1982-12-27 | 1985-07-16 | Leveen Robert F | Production of angiogenetic factor |
GB2146523B (en) * | 1983-09-13 | 1987-01-07 | Ward Page Faulk | Preparation for stimulating growth of blood vessels prepared from amniochorionic tissue and macrophages |
JPH0789936B2 (ja) * | 1985-09-12 | 1995-10-04 | サイオス ノバ インコーポレイテッド | 組換え繊維芽細胞成長因子 |
IL81650A0 (en) * | 1986-02-24 | 1987-09-16 | Robapharm Ag | Purified human angiogenic factor,method for its preparation and pharmaceutical preparations |
-
1986
- 1986-12-11 IL IL8094486A patent/IL80944A/en not_active IP Right Cessation
- 1986-12-11 ES ES86117257T patent/ES2056787T3/es not_active Expired - Lifetime
- 1986-12-11 DE DE3689921T patent/DE3689921T2/de not_active Expired - Fee Related
- 1986-12-11 AT AT86117257T patent/ATE107315T1/de not_active IP Right Cessation
- 1986-12-11 EP EP86117257A patent/EP0226181B1/en not_active Revoked
- 1986-12-12 AU AU67748/87A patent/AU6774887A/en not_active Abandoned
- 1986-12-12 WO PCT/US1986/002669 patent/WO1987003885A1/en active IP Right Grant
- 1986-12-12 KR KR1019870700727A patent/KR960015442B1/ko not_active IP Right Cessation
- 1986-12-15 NZ NZ218631A patent/NZ218631A/en unknown
- 1986-12-16 PT PT83939A patent/PT83939B/pt not_active IP Right Cessation
- 1986-12-16 IE IE863281A patent/IE863281L/xx not_active Application Discontinuation
-
1987
- 1987-08-14 NO NO873437A patent/NO177859C/no unknown
- 1987-08-14 DK DK424387A patent/DK424387A/da not_active Application Discontinuation
-
1988
- 1988-06-16 FI FI882891A patent/FI93843C/fi not_active IP Right Cessation
-
1991
- 1991-04-29 AU AU76299/91A patent/AU650649B2/en not_active Ceased
-
1998
- 1998-01-28 JP JP10015790A patent/JPH10262668A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU6774887A (en) | 1987-07-15 |
ATE107315T1 (de) | 1994-07-15 |
NO177859C (no) | 1995-12-06 |
FI93843B (fi) | 1995-02-28 |
DK424387D0 (da) | 1987-08-14 |
WO1987003885A1 (en) | 1987-07-02 |
FI882891A (fi) | 1988-06-16 |
AU7629991A (en) | 1991-08-08 |
KR880700820A (ko) | 1988-04-12 |
NO873437D0 (no) | 1987-08-14 |
EP0226181A3 (en) | 1989-03-08 |
DK424387A (da) | 1987-08-14 |
IL80944A0 (en) | 1987-03-31 |
DE3689921T2 (de) | 1994-09-22 |
NZ218631A (en) | 1991-07-26 |
PT83939A (en) | 1987-01-01 |
FI882891A0 (fi) | 1988-06-16 |
IL80944A (en) | 1994-10-07 |
AU650649B2 (en) | 1994-06-30 |
KR960015442B1 (ko) | 1996-11-14 |
EP0226181A2 (en) | 1987-06-24 |
FI93843C (fi) | 1995-06-12 |
ES2056787T3 (es) | 1994-10-16 |
DE3689921D1 (de) | 1994-07-21 |
IE863281L (en) | 1987-06-17 |
NO177859B (no) | 1995-08-28 |
NO873437L (no) | 1987-08-14 |
JPH10262668A (ja) | 1998-10-06 |
EP0226181B1 (en) | 1994-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929043D1 (de) | Für androgen-rezeptor-protein kodierende dna | |
ATE110782T1 (de) | Rekombinanter menschlicher endothelzellenwachstumsfaktor. | |
NO177678C (no) | Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein | |
AR006188A1 (es) | "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion". | |
ATE71632T1 (de) | Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression. | |
DE3873397D1 (de) | Bifunktionelle proteine. | |
CA2062969A1 (en) | Recombinantly produced human membrane cofactor protein (mcp) | |
DE3751632D1 (de) | Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen | |
PT83939B (pt) | Metodo para a producao de factor angiogenico da placenta humana capaz de estimular a sintese de proteases, sintese de dna e migracao de celulas endoteliais capilares | |
DK288789D0 (da) | Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse | |
DK229387D0 (da) | Retinoesyreestere, deres fremstilling og farmaceutiske og kosmetiske praeparater deraf | |
ES8605296A1 (es) | Procedimiento de producir factor viii-r humano | |
HUP0001057A2 (hu) | A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
PT85226A (en) | Process for the preparation of novel trombolytic proteins | |
MX9203365A (es) | Factor angiogenico de placenta humana capaz de estimular la sintesis de proteasa de celulas endoteliales, la sintesis de adn y la migracion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19990531 |